The CFO transition appears orderly with an internal interim successor. Monitor for any subsequent filings regarding a permanent CFO appointment or any operational updates that may signal disruption. Given the small market cap and past stock weakness, this change alone is unlikely to move the stock.
Price Chart
Executive Summary
Concord Medical announced the resignation of CFO Wei Jiang, effective June 30, 2026, and the appointment of Botao Shi as interim CFO. Jiang's departure is to focus on the company's subsidiary, Concord Healthcare Group, and is not due to any disagreement. This is a routine management change with no material financial impact.
Key Facts
- CFO Wei Jiang resigned effective June 30, 2026, to focus on subsidiary Concord Healthcare Group (HKEX: 2453.HK).
- Botao Shi appointed interim CFO, effective same date; Shi has been VP and board secretary since August 2024.
- Resignation not due to any disagreement with the company on operations, policies, or financial reporting.
Financial Impact
No financial figures disclosed; routine management change with no direct monetary impact.
Risk Factors
- Potential leadership vacuum if interim CFO is not permanent or if the CFO search is prolonged.
- Negative historical stock performance on prior filings suggests low market confidence; further negative drift possible.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-080089 |
| Document: 0001104659-26-080089-index-headers.html | 0001104659-26-080089 |
| Document: 0001104659-26-080089-index.html | 0001104659-26-080089 |
| Document: 0001104659-26-080089.txt | 0001104659-26-080089 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 2, 2026 13w ago | 6-K | $4.39 $3.56 | ▼ −18.91% | ▼ −21.91% | $3.17 (−27.79%) |
May 18, 2026 19w ago | 6-K | $5.17 $4.79 | ▼ −7.35% | ▼ −12.20% | $3.17 (−38.68%) |
May 13, 2026 20w ago | 6-K | $5.35 $4.53 | ▼ −15.33% | ▼ −19.76% | $3.17 (−40.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access